Your search returned 622 results.

Results
	541.	Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. [electronic resource] by de Wit, R Herrstedt, J Rapoport, B Carides, A D Carides, G Elmer, M Schmidt, C Evans, J K Horgan, K J Producer: 20031210 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	542.	The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination. [electronic resource] by Jordan, K Jahn, F Jahn, P Behlendorf, T Stein, A Ruessel, J Kegel, T Schmoll, H-J Producer: 20111104 In: Bone marrow transplantation vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	543.	Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting. [electronic resource] by Celio, Luigi Denaro, Angela Canova, Stefania Gevorgyan, Arpine Bajetta, Emilio Producer: 20081009 In: Tumori vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	544.	Developing small molecule nonpeptidergic drugs for the treatment of anxiety disorders: is the challenge still ahead? [electronic resource] by Steckler, Thomas Producer: 20110307 In: Current topics in behavioral neurosciences vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	545.	Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug. [electronic resource] by Kast, R E Producer: 20110517 In: Journal of clinical pharmacy and therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	546.	Peripheral neuropathy in non-Hodgkin's lymphoma patients receiving vincristine with and without aprepitant/fosaprepitant. [electronic resource] by Edwards, Jessi K Bossaer, John B Lewis, Paul O Sant, Ashley Producer: 20200928 In: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	547.	Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity. [electronic resource] by Shadle, Craig R Lee, Yih Majumdar, Anup K Petty, Kevin J Gargano, Cynthia Bradstreet, Thomas E Evans, Judith K Blum, Robert A Producer: 20040614 In: Journal of clinical pharmacology vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	548.	A triple-drug combination to prevent nausea and vomiting following BEAM chemotherapy before autologous hematopoietic stem cell transplantation. [electronic resource] by Pielichowski, W Barzal, J Gawronski, K Mlot, B Oborska, S Wasko-Grabowska, A Rzepecki, P Producer: 20120213 In: Transplantation proceedings vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	549.	Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese". [electronic resource] by Di Renzo, Nicola Melillo, Lorella Porretto, Fernando Dargenio, Michela Pavone, Vincenzo Pastore, Domenico Mazza, Patrizio Mannina, Donato Merenda, Anxur Cascavilla, Nicola Greco, Giuseppina Matera, Rosella Bonizzoni, Erminio Celio, Luigi Musso, Maurizio Producer: 20210119 In: Cancer medicine vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	550.	Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers. [electronic resource] by Li, Susie Xiujiang Pequignot, Edward Panebianco, Deborah Lupinacci, Paul Majumdar, Anup Rosen, Laura Ahmed, Tuli Royalty, Jane E Rushmore, Thomas H Murphy, M Gail Petty, Kevin J Producer: 20061121 In: Journal of clinical pharmacology vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	551.	Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. [electronic resource] by Herrstedt, Jørn Muss, Hyman B Warr, David G Hesketh, Paul J Eisenberg, Peter D Raftopoulos, Harry Grunberg, Steven M Gabriel, Munir Rodgers, Anthony Hustad, Carolyn M Horgan, Kevin J Skobieranda, Franck Producer: 20051201 In: Cancer vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	552.	NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test. [electronic resource] by Lelas, Snjezana Li, Yu-Wen Wallace-Boone, Tanya L Taber, Matthew T Newton, Amy E Pieschl, Rick L Davis, Carl D Molski, Thaddeus F Newberry, Kimberly S Parker, Michael F Gillman, Kevin W Bronson, Joanne J Macor, John E Lodge, Nicholas J Producer: 20140813 In: Neuropharmacology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	553.	Aprepitant for chemotherapy-induced nausea and vomiting. [electronic resource] by Flemm, Linda A Producer: 20040803 In: Clinical journal of oncology nursing vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	554.	Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. [electronic resource] by Dando, Toni M Perry, Caroline M Producer: 20040806 In: Drugs vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	555.	Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. [electronic resource] by Zick, Suzanna M Ruffin, Mack T Lee, Julia Normolle, Daniel P Siden, Rivka Alrawi, Sara Brenner, Dean E Producer: 20090903 In: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	556.	Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. [electronic resource] by dos Santos, Lucas Vieira Souza, Fabiano Hahn Brunetto, Andre Tesainer Sasse, Andre Deeke da Silveira Nogueira Lima, João Paulo Producer: 20121119 In: Journal of the National Cancer Institute vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	557.	Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant. [electronic resource] by Jacob, Deepti Busciglio, Irene Burton, Duane Halawi, Houssam Oduyebo, Ibironke Rhoten, Deborah Ryks, Michael Harmsen, W Scott Camilleri, Michael Producer: 20171116 In: American journal of physiology. Gastrointestinal and liver physiology vol. 313 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	558.	Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. [electronic resource] by Liu, Xiaoping Zhu, Yuelan Zheng, Wei Qian, Tangliang Wang, Haiyu Hou, Xiujuan Producer: 20190801 In: Artificial cells, nanomedicine, and biotechnology vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	559.	Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin. [electronic resource] by Jahn, Franziska Riesner, Anica Jahn, Patrick Sieker, Frank Vordermark, Dirk Jordan, Karin Producer: 20151005 In: International journal of radiation oncology, biology, physics vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	560.	Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin. [electronic resource] by Yahata, Hideaki Kobayashi, Hiroaki Sonoda, Kenzo Shimokawa, Mototsugu Ohgami, Tatsuhiro Saito, Toshiaki Ogawa, Shinji Sakai, Kunihiro Ichinoe, Akimasa Ueoka, Yousuke Hasuo, Yasuyuki Nishida, Makoto Masuda, Satohiro Kato, Kiyoko Producer: 20170111 In: International journal of clinical oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
19
20
21
22
23
24
25
26
27
28
29
30
31
32
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 622 results.